MonoFer 100 mg/ml Lösung zur Injektion/Infusion

DRUG2 trials

Sponsors

Medizinische Universitaet Innsbruck, Universitaetsmedizin Goettingen

Conditions

Heart FailureIron deficiency (ID)Mild Cognitive Impairmentrestless leg syndrome

Phase 3

Prospective analysis of the therapeutic efficacy of iron isomaltoside in combination with or without dopaminergic therapy in patients with restless legs syndrome

Not yet recruitingCTIS2024-512117-40-00

Medizinische Universitaet Innsbruckrestless leg syndrome

Target: 140Updated: 2024-10-14

Phase 4

Cognitive Function, Depression, Anxiety, and Quality of Life in Chronic Heart Failure Patients with Iron Deficiency with and without Anaemia: Effects of Intravenous Iron (Ferric Derisomaltose) CogFer-HF Study

Not yet recruitingCTIS2024-515046-17-00

Universitaetsmedizin GoettingenHeart Failure, Iron deficiency (ID), Mild Cognitive Impairment

Target: 40Updated: 2025-07-07